Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4 percent of their body weight after 72 ...

In this strange new world where a weekly injection can quickly achieve what years of attempted diets may fail to do, the ...

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks.

Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.